Stryker Corporation
General ticker "SYK" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $138.8B (TTM average)
Stryker Corporation does not follow the US Stock Market performance with the rate: -30.7%.
Estimated limits based on current volatility of 1.6%: low 315.91$, high 326.20$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-06-30, amount 0.88$ (Y1.13%)
- Total employees count: 56000 (+5.7%) as of 2025
- US accounted for 75.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Inflationary cost increases, Regulatory and compliance, Market competition, Geopolitical risks
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [321.11$, 438.63$]
- 2026-12-31 to 2027-12-31 estimated range: [346.95$, 468.62$]
Financial Metrics affecting the SYK estimates:
- Negative: with PPE of 26.0 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 19.47 > 18.77
- Positive: Inventory ratio change, % of 0.01 <= 0.79
- Positive: 42.26 < Shareholder equity ratio, % of 46.86 <= 63.63
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.35 > 6.06
- Positive: 0.28 < Operating cash flow per share per price, % of 3.73
- Negative: Industry inventory ratio change (median), % of 0.70 > 0.27
Short-term SYK quotes
Long-term SYK plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $20,498.00MM | $22,595.00MM | $25,116.00MM |
| Operating Expenses | $16,610.00MM | $18,906.00MM | $20,227.00MM |
| Operating Income | $3,888.00MM | $3,689.00MM | $4,889.00MM |
| Non-Operating Income | $-215.00MM | $-197.00MM | $-375.00MM |
| Interest Expense | $363.00MM | $409.00MM | $607.00MM |
| R&D Expense | $1,388.00MM | $1,466.00MM | $1,623.00MM |
| Income(Loss) | $3,673.00MM | $3,492.00MM | $4,514.00MM |
| Taxes | $508.00MM | $499.00MM | $1,268.00MM |
| Net Income(Loss)* | $3,165.00MM | $2,993.00MM | $3,246.00MM |
| Stockholders Equity | $18,593.00MM | $20,634.00MM | $22,420.00MM |
| Inventory | $4,843.00MM | $4,774.00MM | $5,310.00MM |
| Assets | $39,912.00MM | $42,971.00MM | $47,844.00MM |
| Operating Cash Flow | $3,711.00MM | $4,242.00MM | $5,044.00MM |
| Capital expenditure | $575.00MM | $755.00MM | $761.00MM |
| Investing Cash Flow | $-962.00MM | $-3,000.00MM | $-4,866.00MM |
| Financing Cash Flow | $-1,594.00MM | $-525.00MM | $113.00MM |
| Earnings Per Share** | $8.34 | $7.86 | $8.49 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.